Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study
Titel:
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study
Auteur:
Pemmaraju, Naveen Garcia, Jacqueline S Potluri, Jalaja Harb, Jason G Sun, Yan Jung, Paul Qin, Qin Q Tantravahi, Srinivas K Verstovsek, Srdan Harrison, Claire